Cardiology, Centrum voor Hart en Vaatziekten (CHVZ), Universitair Ziekenhuis Brussel, 101 Laarbeeklaan, 1090 Brussels, Belgium.
In vivo molecular and cellular imaging (ICMI) center, 109 Laarbeeklaan, 1090 Brussels, Belgium.
Eur Heart J Cardiovasc Imaging. 2020 Jul 1;21(7):709-714. doi: 10.1093/ehjci/jeaa136.
Recent EACVI recommendations described the importance of limiting cardiovascular imaging during the COVID-19 pandemic in order to reduce virus transmission, protect healthcare professionals from contamination, and reduce consumption of personal protective equipment. However, an elevated troponin remains a frequent request for cardiac imaging in COVID-19 patients, partly because it signifies cardiac injury due to a variety of causes and partly because it is known to convey a worse prognosis. The present paper aims to provide guidance to clinicians regarding the appropriateness of cardiac imaging in the context of troponin elevation and myocardial injury, how best to decipher the mechanism of myocardial injury, and how to guide patient management.
近期 EACVI 建议在 COVID-19 大流行期间限制心血管成像，以减少病毒传播、保护医护人员免受污染并减少个人防护设备的消耗。然而，肌钙蛋白升高仍然是 COVID-19 患者进行心脏成像的常见要求，部分原因是它表示由于多种原因导致的心脏损伤，部分原因是已知它预示着更差的预后。本文旨在为临床医生提供关于肌钙蛋白升高和心肌损伤背景下心脏成像的适宜性、如何最好地解读心肌损伤的机制以及如何指导患者管理的指导。
